The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pfizer and sandoz settle patent dispute over mektovi cancer drug copies
Pfizer's Array BioPharma and Sandoz have settled a patent-infringement lawsuit regarding generic versions of the skin-cancer drug Mektovi. The settlement prevents Sandoz from launching its generic products until the expiration of six asserted patents, with three expiring in October 2033, two in August 2030, and one in July 2031.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.